The Latest Cardiac and Vascular News
VANCOUVER, British Columbia, June 13, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH), a global stem cell biotechnology company, announced today that its MyHeart™ platform has been selected as 2018’s “Best New Technology Solution – Drug Development” by MedTech Breakthrough, an independent organization that recognizes the top companies, technologies […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, will host an analyst and institutional investor meeting on Tuesday, June 26, 2018, in New York City from 8:30 a.m. to approximately 10:00 a.m. Eastern Time. The meeting will focus […]
BROSSARD, Quebec, June 12, 2018 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture:ADK) (OTCQB:DGNOF), a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the availability of its first cardio application called HTA. This innovative […]
VANCOUVER, June 11, 2018 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV) (TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on providing innovative, high-quality brands that meet the needs of acute care physicians and patients, today announced that it has received a response from the U.S. Food and Drug Administration (FDA) regarding the regulatory […]
SAN FRANCISCO–(BUSINESS WIRE)–iBeat, a health tech company empowering people to live longer, today announced two investments totaling upward of seven figures from SCOR Life & Health Ventures and Transamerica Ventures. The investments also include enterprise partnerships and booked revenue for the company’s cardiac monitoring smartwatch that will eventually be rolled out to the […]
WESTMINSTER, Colo., June 6, 2018 /PRNewswire/ — CardioNXT and AFTx, related privately-held medical device companies, jointly announced today that the Real-time electrogram Analysis for Drivers of Atrial fibRillation (RADAR) clinical trial has reached full enrollment with 65 treated patients. The RADAR trial focuses on treating patients with Persistent and Long Standing Persistent Atrial Fibrillation (AF). The […]
HONG KONG, June 06, 2018 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSXV:NVH) (FWB:3NH), a global stem cell biotechnology company, is pleased to announce that its wholly owned subsidiary, Novoheart Limited, has been awarded a non-dilutional government grant of C$400,000 from the Innovation and Technology Commission (ITC) of Hong Kong. The […]
REDWOOD CITY, Calif., June 06, 2018 (GLOBE NEWSWIRE) — Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced that its Bioflux device has won the prestigious MedTech Breakthrough Award 2018 for Best Remote Patient Monitoring Solution. MedTech Breakthrough, an independent organization that recognizes […]
VANCOUVER, June 6, 2018 /PRNewswire/ – Correvio Pharma Corp. (NASDAQ: CORV / TSX: CORV), a revenue-generating, specialty pharmaceutical company focused on commercializing hospital drugs, today announced that the Brinavess®study, titled “Vernakalant in hospital emergency practice: safety and effectiveness,” published by José Carbajosa Dalmau (Alicante, Spain), was awarded first prize for the best work published during […]
Amsterdam, the Netherlands – Royal Philips (NYSE: PHG; AEX: PHIA), a global leader in health technology, today announced that it has signed an agreement to acquire EPD Solutions, an innovator in image-guided procedures for cardiac arrhythmias (heart rhythm disorders). EPD’s cardiac imaging and navigation system [1] helps electrophysiologists navigate the heart by generating […]
